H.C.T. van Zaanen

Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity

H.C.T. van Zaanen, Hans van der Lelie, J. Timmer et al. · Cancer · 1994 · 100 citations · Full text

Thiamine deficiency in hematologic malignant tumors

H.C.T. van Zaanen, J. van der Lelie · Cancer · 1992 · 30 citations

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +12

Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial

Sabina Kersting, Julie Dubois, Kazem Nasserinejad et al. · The Lancet Haematology · 2022 · 28 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Venetoclax Consolidation +12

Blocking Interleukin-6 Activity with Chimeric Anti-IL6 Monoclonal Antibodies in Multiple Myeloma: Effects on Soluble IL6 Receptor and Soluble gp130

H.C.T. van Zaanen, HM Lokhorst, L Aarden et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1998 · 27 citations

Inflammation, Clinical Immunology, Vivo Blockage +15

A simple and sensitive method for determining plasma cell isotype and monoclonality in bone marrow using flowcytometry

H.C.T. van Zaanen, RJ Vet, C. M. de Jong et al. · British Journal of Haematology · 1995 · 26 citations